Regenxbio Inc (RGNX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regenxbio Inc   (NASDAQ: RGNX)


Regenxbio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regenxbio Inc's ROI in the second quarter of 2026?
Regenxbio Inc recorded a cumulative net loss of $-196 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -59.96%.

Within the Healthcare sector 526 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3267 to 3957.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -19.36 % -10.2 % -10.63 % -13.03 % -16.26 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 304 271 335 401 461
Return On Investment (TTM) -59.96 % -79.03 % -49.04 % -44.23 % -43.22 %
RGNX's Overall Ranking # 3957 # 3267 # 3360 # 3433 # 2993
Seq. Investment Change TTM -10.73 % -7.17 % -1.73 % -0.97 % -0.59 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -196 -290 -194 -178 -176

RGNX Company Profile >> Back to RGNX Roi Comparisons >> See Annual RGNX Return On Investment



Return On Investment RGNX's Ranking
Within: No.
Industry # 81
Sector # 527
Overall # 3957

Return On Investment Statistics
High Average Low
31.2 %
-24.56 %
-79.03 %
(Jun 30 2018)   (Mar 31 2026)







Financial Statements
Regenxbio Inc's II. Quarter Investments $ 304 Millions RGNX's Balance sheet
Regenxbio Inc's II. Quarter Income $ 23 Millions Quarterly RGNX's Income Statement
RGNX's Income by Division See RGNX's Income by Division


RGNX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 335 363 444 703 983
Y / Y Investment Growth -7.68 % -18.23 % -36.87 % -28.53 % 56.92 %
Net Income in Millions -194 -227 -263 -280 128
Y / Y Net Income Growth - - - - -
Annual Return On Investment -57.88 % -62.6 % -59.39 % -39.88 % 13 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGNX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGNX's Competitors
Subscribers only: Roi for Regenxbio Inc's Suppliers
Subscribers only: Return On Investment for RGNX's Customers

Other Ratios
RGNX's Roa RGNX's Inventory Turnover Ratio RGNX's Growth Rates RGNX's Dividend Statistics
RGNX's Profitability Ratios RGNX's Asset Turnover Ratio RGNX's Dividend Growth
RGNX's Roe RGNX's Valuation Ratios RGNX's Financial Strength Ratios RGNX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:24:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.